Type 1 diabetes mellitus: much progress, many opportunities
- 15 April 2021
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (8)
Abstract
As part of the centennial celebration of insulin’s discovery, this review summarizes the current understanding of the genetics, pathogenesis, treatment, and outcomes in type 1 diabetes (T1D). T1D results from an autoimmune response that leads to destruction of the β cells in the pancreatic islet and requires lifelong insulin therapy. While much has been learned about T1D, it is now clear that there is considerable heterogeneity in T1D with regard to genetics, pathology, response to immune-based therapies, clinical course, and susceptibility to diabetes-related complications. This Review highlights knowledge gaps and opportunities to improve the understanding of T1D pathogenesis and outlines emerging therapies to treat or prevent T1D and reduce the burden of T1D.Keywords
This publication has 146 references indexed in Scilit:
- Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune diseaseCurrent Opinion in Endocrinology, Diabetes and Obesity, 2013
- On the Etiology of Type 1 DiabetesThe American Journal of Pathology, 2012
- The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1Diabetes, 2012
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsJournal of Experimental Medicine, 2012
- How Does Type 1 Diabetes Develop?Diabetes, 2011
- Epidemiology of Type 1 DiabetesEndocrinology and Metabolism Clinics of North America, 2010
- Hypoglycemia in Type 1 Diabetes MellitusEndocrinology and Metabolism Clinics of North America, 2010
- Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist StudyDiabetes, 2010
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000